Dulaglutide, a groundbreaking glucagon-like peptide-1 (GLP-1) receptor agonist, offers a crucial role in managing type 2 diabetes. The increasing need for this medication has spurred the development of US-based manufacturing facilities dedicated to producing dulaglutide. These facilities implemen